ARQ 197 in Subjects With Metastatic Solid Tumors
Clinical trial NCT00302172 · COMPLETED
Trial details
- NCT number
- NCT00302172
- Sponsor
- ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.